Rankings
▼
Calendar
ACRS Q3 2019 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$407M
Q3 2019 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$983,000
-39.6% YoY
Gross Profit
$157,000
16.0% margin
Operating Income
-$23M
-2325.9% margin
Net Income
-$55M
-5627.6% margin
EPS (Diluted)
$-1.34
QoQ Revenue Growth
-83.2%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$24M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$160M
Total Liabilities
$75M
Stockholders' Equity
$85M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$983,000
$2M
-39.6%
Gross Profit
$157,000
$435,000
-63.9%
Operating Income
-$23M
-$33M
+31.6%
Net Income
-$55M
-$33M
-69.0%
Revenue Segments
Laboratory Research Revenue
$983,000
100%
← FY 2019
All Quarters
Q4 2019 →